Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mylan
Mylan
Will Mylan's $29B bid spur other Perrigo suitors to enter the fray?
Fierce Pharma
Fri, 04/10/15 - 04:05 pm
Mylan
Perrigo
M&A
JNJ
Pfizer
AmerisourceBergen
Why Does Mylan Want To Buy Perrigo?
Seeking Alpha
Fri, 04/10/15 - 03:58 pm
M&A
Mylan
Perrigo
Was Mylan's $29B Perrigo bid a takeover defense? Analysts say yes
Fierce Pharma
Thu, 04/9/15 - 10:58 am
Mylan
Perrigo
M&A
Teva Pharmaceutical
Mylan offers to buy rival generic drugmaker Perrigo for $205 per share, or almost $29 billion
Yahoo/AP
Wed, 04/8/15 - 05:14 pm
Mylan
Perrigo
generics
M&A
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Motley Fool
Mon, 02/16/15 - 10:19 am
Pfizer
Hospira
M&A
Teva Pharmaceutical
AbbVie
Bristol-Myers Squibb
Abbott Labs
Mylan
GSK
Mylan introduces methocarbamol injection in US market
PharmaBiz
Sat, 12/13/14 - 12:34 pm
Mylan
methocarbomol
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Mylan Launches First Generic Klor-Con Extended-Release Tablets
Sys-Con Media
Sun, 08/24/14 - 08:51 am
Mylan
generics
Could This 1 Lawsuit Destroy Biogen Idec Stock?
Motley Fool
Tue, 07/22/14 - 05:08 pm
BiogenIdec
Tecfidera
MS
multiple sclerosis
patents
Actavis
Mylan
Synthon Pharmaceuticals
Novartis
Hexal
Sanofi
Zentiva
Why Abbott's Stake In Mylan Will Be Value-Creative
Seeking Alpha
Mon, 07/21/14 - 09:17 am
Abbott Labs
Mylan
Mylan to Buy Abbott’s Generic-Drug Unit, Cut Tax Rate
Bloomberg
Mon, 07/14/14 - 09:30 am
Mylan
M&A
Abbott
generics
taxes
Mylan near multibillion-dollar deal for Abbott drug assets - sources
Global Post
Sat, 07/12/14 - 12:04 pm
Mylan
Abbott Laboratories
Cipla’s Drug Pipeline Makes It $10 Billion Prey: Real M&A
Bloomberg
Wed, 06/18/14 - 04:23 am
Cipla
M&A
India
Mylan
Teva Pharmaceuticals
Mylan settles patent litigation related to Celebrex capsules with Pfizer
Yahoo/Fly on the Wall
Mon, 06/2/14 - 09:49 am
Mylan
Celebrex
patents
Pfizer
generics
Mylan launches generic version of GlaxoSmithKline's Malarone tablets
The Fly on the Wall
Thu, 05/29/14 - 09:28 am
generics
Mylan
GSK
Malarone
malaria
Drug CEOs Say Not Ready to Leave U.S. Yet as Rivals Flee
Bloomberg
Mon, 05/12/14 - 04:20 pm
Pharma CEOs
Pfizer
Mylan
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Xyrem
Jazz Pharmaceuticals
Humulin
Eli Lilly
Premarin
Mylan
Lunesta
Sunovion
Benicar
Daiichi Sankyo
Lantus
Sanofi
Viagra
Pfizer
Gleevec
Novartis
Copaxone
Teva Pharmaceuticals
EpiPen
drug pricing
Mylan's Q1 profit, sales grow; signals "substantial transaction" this year
First Word Pharma
Thu, 05/1/14 - 08:49 am
Mylan
earnings
Stymied by Meda, deal-hungry Mylan could jump on Stada or Mallinckrodt
Fierce Pharma
Wed, 04/30/14 - 12:31 pm
Stada
Meda
Mylan
Mallinckrodt
M&A
Actavis sues U.S. drug regulator over generic Celebrex
Yahoo/Reuters
Tue, 04/29/14 - 08:27 am
Actavis
generics
Pfizer
Celebrex
patents
FDA
Teva Pharmaceuticals
Mylan
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »